Another Pipeline Diabetes Drug Looks Beneficial

(MedPage Today) -- The investigational SGLT2 inhibitor remogliflozin showed benefits for glucose lowering in type 2 diabetes.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news